SPARC and acute myeloid leukemia: As seen in Figure 4, differences in the gene expression levels between inv(16) AML and healthy controls increased significantly for MN1 and SPARC. For DHRS3, the ratio of expression between inv (16) and healthy donors changed only slightly, and for ST18 remained the same.